SnapshotAs of Oct 15, 2026, UniqueBase lists 2 funding records for Iambic Therapeutics; the latest is $100M (Equity) on Nov 10, 2025.
- Funding records
- 2
- Latest round
- $100M · Equity
- Total raised (reported)
- —
- Rows with a source link
- 0 of 2
Overview
Iambic Therapeutics is a company headquartered in San Diego, United States, founded in 2019.
Summary generated from the structured facts on this page.
Funding · 2Funding
Amounts as reported; USD estimates shown only when they matchListed 2 funding records. Latest funding: $100M (Equity), Nov 10, 2025.
Annual trendUnit: USD
| Date | Amount | Investors | Sources |
|---|
| Nov 10, 2025 | $100M · Equity | Abingworth, Alexandria Venture Investments, Alumni Ventures Group, ARK Invest, Ascenta, Catalio, Everbright Biofund, Freeflow Ventures, Illumina Ventures, Pegasus Tech Ventures, Qatar Investment Authority, Regeneron Ventures, Sequoia Capital, Tao Capital Partners, Terra Magnum Capital Partners, Wilson Sonsi ni Goodrich&Rosati, 卡塔尔投资局, 阿布扎比主权财富基金 | ○ No source link |
EvidenceNo source brief is attached to this record. Sources · 0InvestorsAbingworth, Alexandria Venture Investments, Alumni Ventures Group, ARK Invest, Ascenta, Catalio, Everbright Biofund, Freeflow Ventures, Illumina Ventures, Pegasus Tech Ventures, Qatar Investment Authority, Regeneron Ventures, Sequoia Capital, Tao Capital Partners, Terra Magnum Capital Partners, Wilson Sonsi ni Goodrich&Rosati, 卡塔尔投资局, 阿布扎比主权财富基金 |
| Jun 24, 2024 | $50M · Series B | Abingworth, Coatue, Exor Ventures, Illumina Ventures, Mubadala Capital, Nexus Venture Partners, Qatar Investment Authority, Tao Capital Partners | ○ No source link |
EvidenceNo source brief is attached to this record. |
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 2 valuation records.
Annual trendUnit: USD
No chartable valuation estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|
| Nov 10, 2025 | — · Equity | Abingworth, Alexandria Venture Investments, Alumni Ventures Group, ARK Invest, Ascenta, Catalio, Everbright Biofund, Freeflow Ventures, Illumina Ventures, Pegasus Tech Ventures, Qatar Investment Authority, Regeneron Ventures, Sequoia Capital, Tao Capital Partners, Terra Magnum Capital Partners, Wilson Sonsi ni Goodrich&Rosati, 卡塔尔投资局, 阿布扎比主权财富基金 | ○ No source link |
EvidenceNo source brief is attached to this record. Sources · 0InvestorsAbingworth, Alexandria Venture Investments, Alumni Ventures Group, ARK Invest, Ascenta, Catalio, Everbright Biofund, Freeflow Ventures, Illumina Ventures, Pegasus Tech Ventures, Qatar Investment Authority, Regeneron Ventures, Sequoia Capital, Tao Capital Partners, Terra Magnum Capital Partners, Wilson Sonsi ni Goodrich&Rosati, 卡塔尔投资局, 阿布扎比主权财富基金 |
| Jun 24, 2024 | — · Series B | Abingworth, Coatue, Exor Ventures, Illumina Ventures, Mubadala Capital, Nexus Venture Partners, Qatar Investment Authority, Tao Capital Partners | ○ No source link |
EvidenceNo source brief is attached to this record. |
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
Team, products & investors
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.